Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
PUT
Recursion Pharmaceuticals
RXRX
$1.69B
| $4.13M | ﹤0.01% |
550,100
+312,800
| +132% | +$2.73M |
|
3977
CALL
TransUnion
TRU
$15.4B
| $4.12M | ﹤0.01% |
55,600
-88,800
| -61% | -$6.62M |
|
3978
CALL
Alliant Energy
LNT
$18.3B
| $4.12M | ﹤0.01% |
81,000
+19,100
| +31% | +$960K |
|
3979
Chegg
CHGG
$87.5M
| $4.12M | ﹤0.01% |
1,303,748
+697,696
| +115% | +$3.47M |
|
3980
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.7B
| $4.12M | ﹤0.01% |
78,529
-132,529
| -63% | -$7.6M |
|
3981
iShares Russell 1000 Value ETF
IWD
$84.2B
| $4.12M | ﹤0.01% |
23,609
-12,989
| -35% | -$2.27M |
|
3982
CALL
XP
XP
$8.17B
| $4.12M | ﹤0.01% |
234,100
-1,804,000
| -89% | -$37.3M |
|
3983
NewAmsterdam Pharma
NAMS
$3.23B
| $4.11M | ﹤0.01% |
214,154
-240,180
| -53% | -$4.82M |
|
3984
PUT
Dycom Industries
DY
$12.6B
| $4.1M | ﹤0.01% |
24,300
-2,300
| -9% | -$359K |
|
|
JMIA
3985
PUT
Jumia Technologies
JMIA
$772M
| $4.1M | ﹤0.01% |
583,900
+87,200
| +18% | +$537K |
|
3986
Knowles
KN
$3.29B
| $4.09M | ﹤0.01% |
236,949
+109,157
| +85% | +$1.83M |
|
3987
Bitdeer Technologies
BTDR
$2.48B
| $4.09M | ﹤0.01% |
398,548
+398,368
| +221,316% | +$2.73M |
|
3988
CALL
Universal Health Services
UHS
$10B
| $4.09M | ﹤0.01% |
22,100
+2,600
| +13% | +$460K |
|
3989
Sagimet Biosciences
SGMT
$656M
| $4.09M | ﹤0.01% |
1,194,995
+1,164,729
| +3,848% | +$5.34M |
|
3990
CALL
Harrow
HROW
$1.5B
| $4.08M | ﹤0.01% |
195,200
+140,900
| +259% | +$2.11M |
|
|
MLNK
3991
DELISTED
MeridianLink
MLNK
| $4.08M | ﹤0.01% |
190,829
-145,514
| -43% | -$2.71M |
|
3992
Ingevity
NGVT
$2.64B
| $4.08M | ﹤0.01% |
93,233
-33,554
| -26% | -$1.62M |
|
3993
CALL
Tandem Diabetes Care
TNDM
$1.58B
| $4.07M | ﹤0.01% |
101,100
+12,700
| +14% | +$530K |
|
|
OKLO
3994
PUT
Oklo
OKLO
$8.26B
| $4.07M | ﹤0.01% |
+480,400
| New | +$5.4M |
|
3995
CALL
UWM Holdings
UWMC
$2.55B
| $4.07M | ﹤0.01% |
586,700
-217,400
| -27% | -$1.49M |
|
3996
Invesco S&P 500 Pure Growth ETF
RPG
$2.1B
| $4.07M | ﹤0.01% |
109,111
+36,085
| +49% | +$1.29M |
|
3997
CALL
MKS Inc
MKSI
$21B
| $4.06M | ﹤0.01% |
31,100
-26,800
| -46% | -$3.38M |
|
3998
Harmony Gold Mining
HMY
$12.1B
| $4.06M | ﹤0.01% |
442,461
+136,500
| +45% | +$1.22M |
|
|
ARCH
3999
DELISTED
Arch Resources, Inc.
ARCH
| $4.06M | ﹤0.01% |
26,644
-304,487
| -92% | -$48.9M |
|
|
BASE
4000
DELISTED
Couchbase
BASE
| $4.05M | ﹤0.01% |
221,910
+111,749
| +101% | +$2.6M |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.